Angiogenesis and Its Therapeutic Opportunities

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies

(2012) Celeste Leigh Pearce et al.   LANCET ONCOLOGY

Angiogenesis-Related Cytokines, RANKL, and Osteoprotegerin in Multiple Myeloma Patients in relation to Clinical Features and Response to Treatment

(2011) K. Sfiridaki et al.   MEDIATORS OF INFLAMMATION

Inflammatory Mediators and Angiogenic Factors in Choroidal Neovascularization: Pathogenetic Interactions and Therapeutic Implications

(2010) Claudio Campa et al.   MEDIATORS OF INFLAMMATION

Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?

(2009) Kristy J. Gotink et al.   ANGIOGENESIS

Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)

(2009) Stefan Sleijfer et al.   JOURNAL OF CLINICAL ONCOLOGY

Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma

(2008) Guru Sonpavde et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

FDA Approves Sorafenib for Patients With Inoperable Liver Cancer

(2008) Les Lang   GASTROENTEROLOGY

Age-Related Macular Degeneration

(2008) Rama D. Jager et al.   NEW ENGLAND JOURNAL OF MEDICINE